I-Mab price target lowered to $18 from $25 at H.C. Wainwright

H.C. Wainwright analyst Andrew Fein lowered the firm’s price target on I-Mab to $18 from $25 and keeps a Buy rating on the shares. The analyst believes the stock will remain relatively range bound “until multiple Phase 2 data sets can deliver a one-two punch for investors.” The firm dropped the price target following a re-examination of revenue and timeline assumptions.